Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 425 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · derivative · entry 7 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,453 Underlying: Common Stock · 425 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 675 | $57.54 | $38,839.50 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 250 | $38.55 | $9,637.50 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 425 | $35.45 | $15,066.25 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,639 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,067 Underlying: Common Stock · 4,639 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 equal monthly installments thereafter. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,361 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,361 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested in 30 equal monthly installments thereafter. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 4,639 | $1.67 | $7,747.13 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 13:56 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,361 | $1.67 | $8,952.87 |
DisclosureSEC source: 0001179110-19-009566 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · derivative · entry 6 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,250 Underlying: Common Stock · 750 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,275 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,878 Underlying: Common Stock · 1,275 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 675 | $70.00 | $47,250.00 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · nonDerivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 1,350 | $69.02 | $93,177.00 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $38.55 | $28,912.50 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:34 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,275 | $35.45 | $45,198.75 |
DisclosureSEC source: 0001179110-19-009104 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 20:06 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 4,718 | $68.55 | $323,418.90 |
DisclosureSEC source: 0001179110-19-008747 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. F4 · price: Represents the weighted average price of transactions ranging from $68.50 to $68.86. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 17:53 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 7,830 | $69.07 | $540,818.10 |
DisclosureSEC source: 0001179110-19-008728 · edgar.xml · nonDerivative · entry 4 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F4 · price: Represents the weighted average price of transactions ranging from $68.90 to $69.32. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2019 Filed Jul 19, 2019 17:53 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 7,829 | $69.10 | $540,983.90 |
DisclosureSEC source: 0001179110-19-008728 · edgar.xml · nonDerivative · entry 3 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,830 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F4 · price: Represents the weighted average price of transactions ranging from $68.90 to $69.32. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2019 Filed Jul 19, 2019 17:53 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionRestricted Stock Units · Derivative | 29,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-008728 · edgar.xml · derivative · entry 5 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F6 · derivative.exercise_date: On July 14, 2017, the reporting person was was granted 58,824 restricted stock units, vesting in two equal annual installments beginning on July 14, 2018. F6 · derivative.expiration_date: On July 14, 2017, the reporting person was was granted 58,824 restricted stock units, vesting in two equal annual installments beginning on July 14, 2018. Read SEC document |
| July 15, 2019 Filed Jul 19, 2019 17:53 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 13,753 | $70.99 | $976,325.47 |
DisclosureSEC source: 0001179110-19-008728 · edgar.xml · nonDerivative · entry 2 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,659 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| July 15, 2019 Filed Jul 19, 2019 17:53 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionCommon Stock | 29,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-008728 · edgar.xml · nonDerivative · entry 1 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 15, 2019 Filed Jul 22, 2019 20:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-008747 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,706 Underlying: Common Stock · 7,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F6 · derivative.exercise_date: On July 14, 2017, the reporting person was was granted 29,412 restricted stock units, vesting in four equal annual installments beginning on July 14, 2018. F6 · derivative.expiration_date: On July 14, 2017, the reporting person was was granted 29,412 restricted stock units, vesting in four equal annual installments beginning on July 14, 2018. Read SEC document |
| July 15, 2019 Filed Jul 22, 2019 20:06 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,635 | $70.99 | $187,058.65 |
DisclosureSEC source: 0001179110-19-008747 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,098 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| July 15, 2019 Filed Jul 22, 2019 20:06 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 7,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-008747 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 13:57 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-008604 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 1,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 13:57 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,700 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-008604 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,153 Underlying: Common Stock · 1,700 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 13:57 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,700 | $70.00 | $189,000.00 |
DisclosureSEC source: 0001179110-19-008604 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 13:57 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,000 | $38.55 | $38,550.00 |
DisclosureSEC source: 0001179110-19-008604 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 13:57 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,700 | $35.45 | $60,265.00 |
DisclosureSEC source: 0001179110-19-008604 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 14:09 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 9,670 | $70.00 | $676,900.00 |
DisclosureSEC source: 0001179110-19-008605 · edgar.xml · nonDerivative · entry 1 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-008351 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 500 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 850 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-008351 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,853 Underlying: Common Stock · 850 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 1,350 | $67.95 | $91,732.50 |
DisclosureSEC source: 0001179110-19-008351 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 500 | $38.55 | $19,275.00 |
DisclosureSEC source: 0001179110-19-008351 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 850 | $35.45 | $30,132.50 |
DisclosureSEC source: 0001179110-19-008351 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,208 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · derivative · entry 8 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,643 Underlying: Common Stock · 2,208 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 2,208 | $67.85 | $149,812.80 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · nonDerivative · entry 5 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,670 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $67.52 to $68.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionCommon Stock | 2,208 | $38.55 | $85,118.40 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · nonDerivative · entry 4 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,059 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · derivative · entry 7 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,851 Underlying: Common Stock · 10,059 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,657 | $0.00 Strike: $32.50 | $0.00 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · derivative · entry 6 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,619 Underlying: Common Stock · 6,657 shares Expires 2027-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on November 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
SaleCommon Stock | 16,716 | $65.00 | $1,086,540.00 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · nonDerivative · entry 3 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,670 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionCommon Stock | 10,059 | $38.55 | $387,774.45 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · nonDerivative · entry 2 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:01 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionCommon Stock | 6,657 | $32.50 | $216,352.50 |
DisclosureSEC source: 0001179110-19-008350 · edgar.xml · nonDerivative · entry 1 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,650 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,171 Underlying: Common Stock · 4,167 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,840 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,522 Underlying: Common Stock · 2,840 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
SaleCommon Stock | 9,157 | $60.05 | $549,877.85 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $60.00 to $60.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 4,167 | $22.30 | $92,924.10 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 16:02 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,840 | $12.21 | $34,676.40 |
DisclosureSEC source: 0001179110-19-007875 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:02 UTC |
MCCLENNEN PETER APresident
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,629 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-007876 · edgar.xml · derivative · entry 6 MCCLENNEN PETER A · CIK 0001322295 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,910 Underlying: Common Stock · 6,629 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.